Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV Sep. 10, 2024 — Metformin, a drug used to treat type ... well tolerated as HIV pre-exposure prophylaxis (PrEP) before and ...

If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them ... one in 25 people live with HIV. Lenacapavir is a ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

STDs used to be called ... concerned about your risk. Medication. PrEP, which stands for pre-exposure prophylaxis, is a type of daily drug therapy that can prevent HIV infection.

The increasing incidence of sexually transmitted bacterial infections (STIs) is a major public health problem worldwide.

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Cases of HIV are on the rise amongst heterosexual patients according to the latest data from the UK Health and Security ...

Generic tenofovir disoproxil fumarate/emtricitabine the most frequently prescribed medication since 2021. (HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, ...